Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SNSE stock hub

Sensei Biotherapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SNSEis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

31.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SNSE

In the news

Latest news · SNSE

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-74

P25 -105.6P50 -46.5P75 -3.1

ROIC-44.7

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SNSE market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001829802
Company name	Sensei Biotherapeutics, Inc.
Country	United States
Country code	US
Cusip	81728A207
Employees	15
Employees Change	-13%
Employees Change Percent	-46.43
Enterprise value	$11.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-02-04
Isin	US81728A2078
Last refreshed	2026-05-10
Market cap	$31.4M
Market cap category	Nano-Cap
Price	$23.4
Price currency	USD
Sector	Healthcare
Sic	2834
Symbol	SNSE
Website	https://www.senseibio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-67.23%
FCF yield	-65.26%
P/B ratio	1.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-21.1M
Net Income Growth Quarters	4%
Net Income Growth Years	3%
Profit Per Employee	$-1.4M
ROA	-40.81
Roa5y	-29.57
ROCE	-119.5
ROE	-74.01
Roe5y	-51.43
ROIC	-44.7

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	198.69%
Cagr3y	-10.46%
Cagr5y	-37.08%
EPS Growth Quarters	4
EPS Growth Years	3
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$22.9M
Cash	$21.2M
Current Assets	$21.5M
Current Liabilities	$4.3M
Debt	$1.5M
Debt Equity	$0.08
Equity	$18.6M
Interest Coverage	-696.5
Liabilities	$4.3M
Long Term Assets	$1.4M
Long Term Liabilities	$59,000
Net Cash	$19.7M
Net Cash By Market Cap	$62.73
Net Cash Growth	-47.52%
Net Debt Equity	$-1.06
Tangible Book Value	$18.6M
Tangible Book Value Per Share	$14.74
WACC	3.17

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.06
Net Working Capital	$-2.5M
Quick ratio	4.98
Working Capital	$17.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.4%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	198.47%
200-day SMA	15.14
3Y total return	-28.22%
50-day SMA	29.7
50-day SMA vs 200-day SMA	50over200
5Y total return	-90.13%
All Time High	530
All Time High Change	-95.58%
All Time High Date	2021-02-04
All Time Low	5
All Time Low Change	368%
All Time Low Date	2025-03-31
ATR	3.2
Beta	-0.18
Beta1y	0.49
Beta2y	1.59
Ch YTD	119.3
High	25.24
High52	36.76
High52 Date	2026-02-25
High52ch	-36.34%
Low	22.75
Low52	5.25
Low52 Date	2025-05-22
Low52ch	345.71%
Ma50ch	-21.21%
Price vs 200-day SMA	54.53%
RSI	33.99
RSI Monthly	49.8
RSI Weekly	54.56
Sharpe ratio	1.13x
Sortino ratio	3.7
Total Return	-0.4%
Tr YTD	119.3
Tr1m	-22.49%
Tr1w	-13.2%
Tr3m	164.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.62
Operating Income	$-22.3M
Price target	$65
Price Target Change	$178

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	810,907%
Float Percent	60.5%
Net Borrowing	-790,000
Shares Insiders	2.09%
Shares Institutions	15.31%
Shares Out	1,340,333
Shares Qo Q	0.01%
Shares Yo Y	0.4%
Short Ratio	12.01
Short Shares	63.85

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-21.7M
Average Volume	32,152x
Bv Per Share	14.74
CAPEX	$-16,000
Ch1m	-22.49
Ch1w	-13.2
Ch1y	198.5
Ch3m	164.1
Ch3y	-28.22
Ch5y	-90.13
Ch6m	157.1
Change	-1.52%
Change From Open	-1.52
Close	23.76
Days Gap	0
Depreciation Amortization	139,000
Dollar Volume	379,735.2
Earnings Date	2026-05-22
Earnings Time	bmo
EBIT	$-22.3M
EBITDA	$-22.1M
EPS	$-16.72
F Score	1
FCF	$-20.5M
FCF EV Yield	-175.12x
FCF Per Share	$-15.27
Financing CF	-645,000
Fiscal Year End	December
Founded	2,005
Investing CF	19,772,000
Ipr	23.16
Iprfo	-95.26
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-30
Last Report Date	2025-12-31
Last Split Date	2025-06-17
Last Split Type	Reverse
Last10k Filing Date	2026-03-30
Ma150	17.42
Ma150ch	34.31%
Ma20	28.69
Ma20ch	-18.44%
Net CF	-1,326,000
Next Earnings Date	2026-05-22
Open	23.76
Optionable	No
Position In Range	26.1
Post Close	23.4
Postmarket Change Percent	-0.06
Postmarket Price	$23.39
Ppne	1,377,000
Price Date	2026-05-08
Ptbv Ratio	1.69
Relative Volume	0.5x
Share Based Comp	1,274,000
Tr6m	157.14%
Us State	Maryland
Volume	16,228

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SNSE pay a dividend?

Capital-return profile for this ticker.

Performance

SNSE stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SNSE?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.3%

Float: +60.5% of shares outstanding

Insider ownership

+2.1%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SNSE momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

34.0

Neutral momentum band

Price vs 200-day MA

+54.5%

50/200-day relationship not available

Beta (5Y)

-0.18

Less volatile than the market

Sharpe ratio

1.13

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SNSE

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SNSE stock rating?

Sensei Biotherapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SNSE analysis?

The full report lives at /stocks/SNSE/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SNSE?

The latest report frames SNSE around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SNSE page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.